PT Itama Ranoraya TbkISX:IRRA +0.53%81 Days Payable is 275.42 as of Mar. 2026, which is 133% above its 10-year median of 118.32. GuruFocus rates ISX:IRRA with a GF Score™ of 81/100 and a GF Value™ of Rp536.07 (Possible Value Trap). The stock has 8 warning signs investors should review. Among 115 Medical Distribution companies, PT Itama Ranoraya Tbk ranks better than 90.43% on this metric.
PT Itama Ranoraya Tbk Days Payable Historical Data
* Premium members only.
The historical data trend for PT Itama Ranoraya Tbk's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ISX:IRRA vs MCK, CAH, COR: Days Payable Comparison
For the Medical Distribution subindustry, PT Itama Ranoraya Tbk's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
PT Itama Ranoraya Tbk Days Payable vs Medical Distribution Industry
For the Medical Distribution industry and Healthcare sector, PT Itama Ranoraya Tbk's Days Payable distribution charts can be found below:
* The bar in red indicates where PT Itama Ranoraya Tbk's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
PT Itama Ranoraya Tbk's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
PT Itama Ranoraya Tbk (ISX:IRRA) has a Days Payable of 275.42 as of Mar. 2026. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Itama Ranoraya Tbk and its competitors. This is 133% above median its historical median of 118.32. Over the past decade, PT Itama Ranoraya Tbk's Days Payable has ranged from 72.12 to 405.22. According to the industry distribution chart, PT Itama Ranoraya Tbk ranks #11 out of 115 companies in the Medical Distribution industry, placing it in the top 9.6%.
Is PT Itama Ranoraya Tbk's Days Payable too high?
PT Itama Ranoraya Tbk's current Days Payable of 275.42 is 133% above median its 10-year median of 118.32. Over the past 10 years, this metric has ranged from a low of 72.12 to a high of 405.22. The Medical Distribution industry median Days Payable is 79.81. PT Itama Ranoraya Tbk's value of 275.42 is 245.1% above this industry median. Based on the distribution chart, PT Itama Ranoraya Tbk ranks #11 out of 115 companies in the Medical Distribution industry, which is in the top quartile — a strong position relative to peers. Overall, PT Itama Ranoraya Tbk has a GF Score™ of 81/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does PT Itama Ranoraya Tbk's Days Payable compare to MCK and CAH?
According to the Medical Distribution industry distribution chart, PT Itama Ranoraya Tbk ranks #11 out of 115 companies for Days Payable. This places PT Itama Ranoraya Tbk in the top 10% of its industry — outperforming the majority of peers. The industry median Days Payable is 79.81. PT Itama Ranoraya Tbk's value of 275.42 is 245.1% above this benchmark. Historically, PT Itama Ranoraya Tbk's own Days Payable has ranged from 72.12 to 405.22 over the past decade. While the company's 10-year median is 118.32 vs. the industry median of 79.81, PT Itama Ranoraya Tbk has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Medical Distribution company?
The median Days Payable among Medical Distribution companies is 79.81, based on 115 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. PT Itama Ranoraya Tbk's current Days Payable of 275.42 is 245.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on PT Itama Ranoraya Tbk and its competitors. For the Medical Distribution industry, the median Days Payable is 79.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. PT Itama Ranoraya Tbk's current Days Payable is 275.42, which is 133% above median its own 10-year median of 118.32. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is PT Itama Ranoraya Tbk stock overvalued right now?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk (ISX:IRRA) is currently considered Possible Value Trap. The stock's GF Value™ is Rp536.07, compared to a current price of Rp376.00 — trading 29.9% below its estimated fair value. The current Days Payable is 275.42, which is 133% above median its 10-year median of 118.32 and 245.1% above the Medical Distribution industry median of 79.81. PT Itama Ranoraya Tbk's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For PT Itama Ranoraya Tbk (ISX:IRRA), the current Days Payable is 275.42 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is PT Itama Ranoraya Tbk (ISX:IRRA) Overvalued in 2026?
Based on GuruFocus' analysis, PT Itama Ranoraya Tbk stock appears to be undervalued.
The current stock price of Rp376.00 is trading 29.9% below its estimated GF Value™ of Rp536.07.
GuruFocus considers PT Itama Ranoraya Tbk to be Possible Value Trap.
Key valuation signals for ISX:IRRA:
Days Payable: 275.42 (133% above median its 10-year median of 118.32)
GF Value™: Rp536.07 vs. price of Rp376.00 (29.9% below fair value)
Industry Position: 245.1% above the Medical Distribution median (#11 of 115)
No single metric tells the full story. See the ISX:IRRA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
PT Itama Ranoraya Tbk focuses on the trade and distribution of medical devices. The company distributes medical devices such as Oneject auto disable syringe, Abbott diagnostics, TerumoBCT, Ortho Clinical diagnostics and others. It business segment includes Vitro Diagnostic Products, Non-Electromedical Sterile Medical Devices, Electromedical Sterile Medical Devices and Other Segments. The key revenue generating segments of the company are In Vitro Diagnostic product.
81GF Score
Get the complete analysis for ISX:IRRA
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ISX:IRRA has been successfully added to your 
